Engineering defected 2D Pd/H-TiO(2) nanosonosensitizers for hypoxia alleviation and enhanced sono-chemodynamic cancer nanotherapy

BACKGROUND: Sonodynamic therapy (SDT) is a burgeoning modality for cancer therapy owing to its high tissue-penetrating capability, controllability and safety. Whereas, the undesirable reactive oxygen species (ROS) yield of sonosensitizers and tumor hypoxia are two vulnerable spots of SDT. Therefore,...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiao, Xiaohui, Xue, Liyun, Huang, Hui, Dai, Xinyue, Chen, Yu, Ding, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9003983/
https://www.ncbi.nlm.nih.gov/pubmed/35413839
http://dx.doi.org/10.1186/s12951-022-01398-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9003983/
https://www.ncbi.nlm.nih.gov/pubmed/35413839
http://dx.doi.org/10.1186/s12951-022-01398-6

Ejemplares similares